Haemonetics Corporation (HAE)

Current ratio

		Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Total current assets	US$ in thousands	934,975	1,005,870	955,902	978,578	768,903	764,982	865,744	801,607	769,722	706,309	715,789	687,783	756,031	729,455	699,246	684,368	693,546	668,348	760,279	759,410
Total current liabilities	US$ in thousands	578,113	253,233	273,946	260,076	300,383	261,755	264,215	236,939	251,816	226,889	262,175	180,487	442,266	355,411	288,470	228,339	253,495	194,384	338,568	407,827
Current ratio		1.62	3.97	3.49	3.76	2.56	2.92	3.28	3.38	3.06	3.11	2.73	3.81	1.71	2.05	2.42	3.00	2.74	3.44	2.25	1.86

March 31, 2025 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $934,975K ÷ $578,113K
= 1.62

Haemonetics Corporation's current ratio has displayed fluctuations over the analyzed period from June 30, 2020, to March 31, 2025. The current ratio measures the company's ability to cover its short-term liabilities with its current assets.

The current ratio started at 1.86 on June 30, 2020, and showed an increasing trend, reaching its peak at 3.97 on December 31, 2024. A current ratio above 1 indicates that the company has more current assets than current liabilities, which is generally seen as a positive sign.

However, there were periods of fluctuation within the trend. For example, the ratio dropped to 1.62 on March 31, 2025, indicating a potential liquidity issue at that particular point in time.

Overall, the current ratio of Haemonetics Corporation has generally been healthy, with the ability to cover its short-term obligations comfortably. However, the fluctuations observed suggest the need for continued monitoring of the company's liquidity position to ensure ongoing financial stability.